These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38236756)

  • 1. Preoperative Renin-Angiotensin System Antagonists Intake and Blood Pressure Responses During Ambulatory Surgical Procedures: A Prospective Cohort Study.
    Gurunathan U; Roe A; Milligan C; Hay K; Ravichandran G; Chawla G
    Anesth Analg; 2024 Apr; 138(4):763-774. PubMed ID: 38236756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
    Steely AM; Callas PW; Bertges DJ;
    J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome.
    Zreikat HH; Harpe SE; Slattum PW; Mays DP; Essah PA; Cheang KI
    Metabolism; 2014 Mar; 63(3):392-9. PubMed ID: 24393433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
    Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
    BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Number of Pills, Rather Than the Type of Renin-Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study.
    Sarzani R; Giulietti F; Filipponi A; Marziali S; Ristori L; Buscarini S; Garbuglia C; Biondini S; Allevi M; Spannella F
    Adv Ther; 2021 Jul; 38(7):4013-4025. PubMed ID: 34115328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
    Yokoyama K; Yang W; Preblick R; Frech-Tamas F
    J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation of Angiotensin-Converting Enzyme Inhibitors on the Day of Surgery Is Not Associated With Increased Risk of Hypotension Upon Induction of General Anesthesia in Elective Noncardiac Surgeries.
    Yoon U; Setren A; Chen A; Nguyen T; Torjman M; Kennedy T
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):508-513. PubMed ID: 32029371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
    Fosbøl EL; Butt JH; Østergaard L; Andersson C; Selmer C; Kragholm K; Schou M; Phelps M; Gislason GH; Gerds TA; Torp-Pedersen C; Køber L
    JAMA; 2020 Jul; 324(2):168-177. PubMed ID: 32558877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis.
    Batty JA; Tang M; Hall M; Ferrari R; Strauss MH; Hall AS
    Syst Rev; 2018 Aug; 7(1):131. PubMed ID: 30144828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blockade is associated with increased risk of giant cell arteritis.
    Zhao SS; Lyu H; Zeng C; Lei G; Wei J; Mackie SL
    Rheumatology (Oxford); 2023 Jun; 62(6):2203-2210. PubMed ID: 36255257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists.
    Brabant SM; Bertrand M; Eyraud D; Darmon PL; Coriat P
    Anesth Analg; 1999 Dec; 89(6):1388-92. PubMed ID: 10589613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin-Aldosterone System Blockade after AKI with or without Recovery among US Veterans with Diabetic Kidney Disease.
    Murphy DP; Wolfson J; Reule S; Johansen KL; Ishani A; Drawz PE
    J Am Soc Nephrol; 2023 Oct; 34(10):1721-1732. PubMed ID: 37545022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT.
    King JB; Berchie RO; Derington CG; Marcum ZA; Scharfstein DO; Greene TH; Herrick JS; Jacobs JA; Zheutlin AR; Bress AP; Cohen JB
    J Am Heart Assoc; 2023 Sep; 12(17):e030311. PubMed ID: 37646208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Effects of Combination of Renin-Angiotensin-Aldosterone System Inhibitors on Central Aortic Blood Pressure: A Cross-Sectional Observational Study in Hypertensive Outpatients.
    Pradhan A; Vishwakarma P; Bhandari M; Sethi R; Narain VS
    Cardiovasc Ther; 2020; 2020():4349612. PubMed ID: 32983258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
    Zhang P; Zhu L; Cai J; Lei F; Qin JJ; Xie J; Liu YM; Zhao YC; Huang X; Lin L; Xia M; Chen MM; Cheng X; Zhang X; Guo D; Peng Y; Ji YX; Chen J; She ZG; Wang Y; Xu Q; Tan R; Wang H; Lin J; Luo P; Fu S; Cai H; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu M; Chen M; Zhang XJ; Wang X; Touyz RM; Xia J; Zhang BH; Huang X; Yuan Y; Loomba R; Liu PP; Li H
    Circ Res; 2020 Jun; 126(12):1671-1681. PubMed ID: 32302265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should renin-angiotensin system inhibitors be held prior to major surgery?
    Legrand M
    Br J Anaesth; 2024 May; 132(5):831-834. PubMed ID: 38642964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin system inhibitors in a general surgical population.
    Comfere T; Sprung J; Kumar MM; Draper M; Wilson DP; Williams BA; Danielson DR; Liedl L; Warner DO
    Anesth Analg; 2005 Mar; 100(3):636-644. PubMed ID: 15728043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.